200 related articles for article (PubMed ID: 14623893)
1. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
2. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription.
Ohno M; Zannini M; Levy O; Carrasco N; di Lauro R
Mol Cell Biol; 1999 Mar; 19(3):2051-60. PubMed ID: 10022892
[TBL] [Abstract][Full Text] [Related]
3. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
4. Pax-8 is essential for regulation of the thyroglobulin gene by transforming growth factor-beta1.
Kang HC; Ohmori M; Harii N; Endo T; Onaya T
Endocrinology; 2001 Jan; 142(1):267-75. PubMed ID: 11145590
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the human sodium/iodide symporter gene by Pax8 and TTF-1.
Schmitt TL; Espinoza CR; Loos U
Exp Clin Endocrinol Diabetes; 2001; 109(1):27-31. PubMed ID: 11573135
[TBL] [Abstract][Full Text] [Related]
9. A novel thyroid transcription factor is essential for thyrotropin-induced up-regulation of Na+/I- symporter gene expression.
Ohmori M; Endo T; Harii N; Onaya T
Mol Endocrinol; 1998 May; 12(5):727-36. PubMed ID: 9605935
[TBL] [Abstract][Full Text] [Related]
10. A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.
Ohta S; Takeuchi M; Deguchi M; Tsuji T; Gahara Y; Nagata K
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):395-404. PubMed ID: 10947953
[TBL] [Abstract][Full Text] [Related]
11. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
Nagarajan RP; Zhang J; Li W; Chen Y
J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
[TBL] [Abstract][Full Text] [Related]
13. Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential.
Poleev A; Okladnova O; Musti AM; Schneider S; Royer-Pokora B; Plachov D
Eur J Biochem; 1997 Aug; 247(3):860-9. PubMed ID: 9288908
[TBL] [Abstract][Full Text] [Related]
14. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
15. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
[TBL] [Abstract][Full Text] [Related]
17. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]